{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:35:26Z","timestamp":1782398126216,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,27]]},"DOI":"10.7759\/cureus.83090","type":"journal-article","created":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T22:48:08Z","timestamp":1745794088000},"source":"Crossref","is-referenced-by-count":2,"title":["Challenges in Diagnosing and Differentiating IgG4-Related Disease From Sj\u00f6gren\u2019s Disease: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Dosbai","family":"Saparov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandr","family":"Markov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarang","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakirat","family":"Gold-Olufadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Becerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neharika","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yevheniia","family":"Andriushchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avezbakiyev","family":"Boris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Terebelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"11","author":"Kamisawa T","year":"2015","unstructured":"Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015, 11:1460-71. 10.1016\/S0140-6736(14)60720-0","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214603","article-title":"Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts","volume":"78","author":"Wallace ZS","year":"2019","unstructured":"Wallace ZS, Zhang Y, Perugino CA, Naden R, Choi HK, Stone JH. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis. 2019, 78:406-12. 10.1136\/annrheumdis-2018-214603","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key397","article-title":"Sex disparities in clinical characteristics and prognosis of immunoglobulin G4-related disease: a prospective study of 403 patients","volume":"58","author":"Wang L","year":"2019","unstructured":"Wang L, Zhang P, Zhang X, et al.. Sex disparities in clinical characteristics and prognosis of immunoglobulin G4-related disease: a prospective study of 403 patients. Rheumatology (Oxford). 2019, 58:820-30. 10.1093\/rheumatology\/key397","journal-title":"Rheumatology (Oxford)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-223950","article-title":"Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults","volume":"82","author":"Wallace ZS","year":"2023","unstructured":"Wallace ZS, Miles G, Smolkina E, et al.. Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults. Ann Rheum Dis. 2023, 82:957-62. 10.1136\/ard-2023-223950","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/srep32035","article-title":"Diagnostic performance of serum IgG4 level for IgG4-related disease: a meta-analysis","volume":"6","author":"Xu WL","year":"2016","unstructured":"Xu WL, Ling YC, Wang ZK, Deng F. Diagnostic performance of serum IgG4 level for IgG4-related disease: a meta-analysis. Sci Rep. 2016, 6:32035. 10.1038\/srep32035","journal-title":"Sci Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.205526","article-title":"IgG4-related disease: what a hematologist needs to know","volume":"104","author":"Chen LY","year":"2019","unstructured":"Chen LY, Mattman A, Seidman MA, Carruthers MN. IgG4-related disease: what a hematologist needs to know. Haematologica. 2019, 104:444-55. 10.3324\/haematol.2018.205526","journal-title":"Haematologica"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216561","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease","volume":"79","author":"Wallace ZS","year":"2020","unstructured":"Wallace ZS, Naden RP, Chari S, et al.. The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020, 79:77-87. 10.1136\/annrheumdis-2019-216561","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(19)30017-7","article-title":"Management of IgG4-related disease","volume":"1","author":"Zhang W","year":"2019","unstructured":"Zhang W, Stone JH. Management of IgG4-related disease. Lancet Rheumatol. 2019, 1:55-65. 10.1016\/S2665-9913(19)30017-7","journal-title":"Lancet Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1567-2","article-title":"Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients","volume":"20","author":"Wang L","year":"2018","unstructured":"Wang L, Zhang P, Wang M, et al.. Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients. Arthritis Res Ther. 2018, 20:65. 10.1186\/s13075-018-1567-2","journal-title":"Arthritis Res Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2019.12.029","article-title":"Long-term efficacy of maintenance therapy with rituximab for IgG4-related disease","volume":"74","author":"Campochiaro C","year":"2020","unstructured":"Campochiaro C, Della-Torre E, Lanzillotta M, et al.. Long-term efficacy of maintenance therapy with rituximab for IgG4-related disease. Eur J Intern Med. 2020, 74:92-8. 10.1016\/j.ejim.2019.12.029","journal-title":"Eur J Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/imj.14331","article-title":"Immunoglobulin G(4) related disease: a single-centre experience from South Australia","volume":"49","author":"Pucar PA","year":"2019","unstructured":"Pucar PA, Nolan J, Hissaria P. Immunoglobulin G(4) related disease: a single-centre experience from South Australia. Intern Med J. 2019, 49:1099-104. 10.1111\/imj.14331","journal-title":"Intern Med J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2021-207748","article-title":"IgG4-related disease: an analysis of the clinicopathological spectrum: UK centre experience","volume":"76","author":"Dassanayaka W","year":"2023","unstructured":"Dassanayaka W, Liyanaarachchi KS, Ala A, Bagwan IN. IgG4-related disease: an analysis of the clinicopathological spectrum: UK centre experience. J Clin Pathol. 2023, 76:53-8. 10.1136\/jclinpath-2021-207748","journal-title":"J Clin Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02652-2","article-title":"The risk of malignancy in patients with IgG4-related disease: a systematic review and meta-analysis","volume":"24","author":"Yu T","year":"2022","unstructured":"Yu T, Wu Y, Liu J, Zhuang Y, Jin X, Wang L. The risk of malignancy in patients with IgG4-related disease: a systematic review and meta-analysis. Arthritis Res Ther. 2022, 24:14. 10.1186\/s13075-021-02652-2","journal-title":"Arthritis Res Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61585-z","article-title":"Malignancy and IgG4-related disease: the incidence, related factors and prognosis from a prospective cohort study in China","volume":"10","author":"Tang H","year":"2020","unstructured":"Tang H, Yang H, Zhang P, et al.. Malignancy and IgG4-related disease: the incidence, related factors and prognosis from a prospective cohort study in China. Sci Rep. 2020, 10:4910. 10.1038\/s41598-020-61585-z","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-021-00326-8","article-title":"Malignancy risk of immunoglobin G4-related disease: evidence from a large cohort multicenter retrospective study","volume":"8","author":"Liu Y","year":"2021","unstructured":"Liu Y, Fu J, Ning X, et al.. Malignancy risk of immunoglobin G4-related disease: evidence from a large cohort multicenter retrospective study. Rheumatol Ther. 2021, 8:1207-21. 10.1007\/s40744-021-00326-8","journal-title":"Rheumatol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/art.39773","article-title":"Association of IgG4-related disease with history of malignancy","volume":"68","author":"Wallace ZS","year":"2016","unstructured":"Wallace ZS, Wallace CJ, Lu N, Choi HK, Stone JH. Association of IgG4-related disease with history of malignancy. Arthritis Rheumatol. 2016, 68:2283-9. 10.1002\/art.39773","journal-title":"Arthritis Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-239976","article-title":"IgG4-related disease: a great mimicker of lung cancer","volume":"14","author":"Simon NL","year":"2021","unstructured":"Simon NL, Negmeldin M. IgG4-related disease: a great mimicker of lung cancer. BMJ Case Rep. 2021, 14:239976. 10.1136\/bcr-2020-239976","journal-title":"BMJ Case Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20210105","article-title":"(18)F-FDG PET\/CT manifestations of IgG4-related disease","volume":"94","author":"Tang CY","year":"2021","unstructured":"Tang CY, Chua WM, Cheng LT, Fong W, Zaheer S, Lam WW. (18)F-FDG PET\/CT manifestations of IgG4-related disease. Br J Radiol. 2021, 94:20210105. 10.1259\/bjr.20210105","journal-title":"Br J Radiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000001153","article-title":"Utility of FDG PET\/CT for differential diagnosis of patients clinically suspected of IgG4-related disease","volume":"41","author":"Lee J","year":"2016","unstructured":"Lee J, Hyun SH, Kim S, et al.. Utility of FDG PET\/CT for differential diagnosis of patients clinically suspected of IgG4-related disease. Clin Nucl Med. 2016, 41:e237-43. 10.1097\/RLU.0000000000001153","journal-title":"Clin Nucl Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP41XCVBHEQCEL","article-title":"Relatively restricted migration of polyclonal IgG4 may mimic a monoclonal gammopathy in IgG4-related disease","volume":"142","author":"Jacobs JF","year":"2014","unstructured":"Jacobs JF, van der Molen RG, Keren DF. Relatively restricted migration of polyclonal IgG4 may mimic a monoclonal gammopathy in IgG4-related disease. Am J Clin Pathol. 2014, 142:76-81. 10.1309\/AJCP41XCVBHEQCEL","journal-title":"Am J Clin Pathol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-024-07062-8","article-title":"Elevated polyclonal IgG4 mimicking a monoclonal gammopathy in IgG4-related disease-a case-based review","volume":"43","author":"Lu C","year":"2024","unstructured":"Lu C, He D, Wang R, et al.. Elevated polyclonal IgG4 mimicking a monoclonal gammopathy in IgG4-related disease-a case-based review. Clin Rheumatol. 2024, 43:3019-28. 10.1007\/s10067-024-07062-8","journal-title":"Clin Rheumatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez380","article-title":"Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis","volume":"59","author":"Omar D","year":"2020","unstructured":"Omar D, Chen Y, Cong Y, Dong L. Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis. Rheumatology (Oxford). 2020, 59:718-26. 10.1093\/rheumatology\/kez380","journal-title":"Rheumatology (Oxford)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/355758-challenges-in-diagnosing-and-differentiating-igg4-related-disease-from-sjgrens-disease-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T22:48:09Z","timestamp":1745794089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/355758-challenges-in-diagnosing-and-differentiating-igg4-related-disease-from-sjgrens-disease-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,27]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.83090","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,27]]}}}